Back to JENNISON ASSOCIATES LLC JENNISON ASSOCIATES LLC

NVONVO
Showing 6 of 28 quarters

Position history for JENNISON ASSOCIATES LLCJENNISON ASSOCIATES LLC's holdings in Novo Nordisk A/S

No. Jennison Associates exited its NVO (Novo Nordisk) position in Q4 2025. Its Q3 2025 13F listed 1,226,004 shares worth $68M. Jennison Associates first reported NVO in Q1 2019 and held it in 27 quarterly 13F filings.

Final Value

$0

Final Shares

0

Total Value Change

-$2.4B

Total Shares Change

-20.2M

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2025-Q4
Latest
Exited
0
-100.0%
$00.0%$48.46
0
2025-Q3
Decreased
1.2M
-93.5%
$68M0.0%$52.85
0
2025-Q2
Increased
18.9M
+0.3%
$1.3B0.8%$65.01
45
2025-Q1
Decreased
18.8M
-5.6%
$1.3B0.9%$65.40
0
2024-Q4
Decreased
19.9M
-1.2%
$1.7B1.0%$79.73
0
2024-Q3
Decreased
20.2M
-4.8%
$2.4B1.5%$110.37
0

Other major holders of NVO: FMR LLC, RENAISSANCE TECHNOLOGIES LLC, MORGAN STANLEY

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used